To determine whether OSU-ERb-12 can inhibit tumor growth in vivo, we generated PDXs of HGSOC in NSG mice and treated tumor-bearing mice with two doses of OSU-ERb-12 for 19 days. Here, ESR2 is linked to neoplasm.